These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 9989788)

  • 1. Bullous pemphigoid sera that contain antibodies to BPAg2 also contain antibodies to LABD97 that recognize epitopes distal to the NC16A domain.
    Egan CA; Taylor TB; Meyer LJ; Petersen MJ; Zone JJ
    J Invest Dermatol; 1999 Feb; 112(2):148-52. PubMed ID: 9989788
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The 97 kDa linear IgA bullous disease antigen is identical to a portion of the extracellular domain of the 180 kDa bullous pemphigoid antigen, BPAg2.
    Zone JJ; Taylor TB; Meyer LJ; Petersen MJ
    J Invest Dermatol; 1998 Mar; 110(3):207-10. PubMed ID: 9506436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autoantibodies in a subgroup of patients with linear IgA disease react with the NC16A domain of BP1801.
    Zillikens D; Herzele K; Georgi M; Schmidt E; Chimanovitch I; Schumann H; Mascaro JM; Diaz LA; Bruckner-Tuderman L; Bröcker EB; Giudice GJ
    J Invest Dermatol; 1999 Dec; 113(6):947-53. PubMed ID: 10594735
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 97 kDa linear IgA bullous dermatosis antigen localizes in the lamina lucida between the NC16A and carboxyl terminal domains of the 180 kDa bullous pemphigoid antigen.
    Ishiko A; Shimizu H; Masunaga T; Yancey KB; Giudice GJ; Zone JJ; Nishikawa T
    J Invest Dermatol; 1998 Jul; 111(1):93-6. PubMed ID: 9665393
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IgG anti-LABD97 antibodies in bullous pemphigoid patients' sera react with the mid-portion of the BPAg2 ectodomain.
    Egan CA; Reddy D; Nie Z; Taylor TB; Schmidt LA; Meyer LJ; Petersen MJ; Hashimoto T; Marinkovich MP; Zone JJ
    J Invest Dermatol; 2001 Feb; 116(2):348-50. PubMed ID: 11180014
    [No Abstract]   [Full Text] [Related]  

  • 6. Human autoantibodies against the 230-kD bullous pemphigoid antigen (BPAG1) bind only to the intracellular domain of the hemidesmosome, whereas those against the 180-kD bullous pemphigoid antigen (BPAG2) bind along the plasma membrane of the hemidesmosome in normal human and swine skin.
    Ishiko A; Shimizu H; Kikuchi A; Ebihara T; Hashimoto T; Nishikawa T
    J Clin Invest; 1993 Apr; 91(4):1608-15. PubMed ID: 7682575
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of IgG autoantibodies in the sera of patients with bullous and gestational pemphigoid: ELISA studies utilizing a baculovirus-encoded form of bullous pemphigoid antigen 2.
    Haase C; Büdinger L; Borradori L; Yee C; Merk HF; Yancey K; Hertl M
    J Invest Dermatol; 1998 Mar; 110(3):282-6. PubMed ID: 9506450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autoantibodies in lichen planus pemphigoides react with a novel epitope within the C-terminal NC16A domain of BP180.
    Zillikens D; Caux F; Mascaro JM; Wesselmann U; Schmidt E; Prost C; Callen JP; Bröcker EB; Diaz LA; Giudice GJ
    J Invest Dermatol; 1999 Jul; 113(1):117-21. PubMed ID: 10417629
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunofluorescence-negative bullous pemphigoid sera contain antibodies mostly directed against the 180 kDa bullous pemphigoid antigen (BPAg2).
    Ghohestani RF; Claudy A
    Br J Dermatol; 1997 Aug; 137(2):306-7. PubMed ID: 9292090
    [No Abstract]   [Full Text] [Related]  

  • 10. Molecular cloning of canine bullous pemphigoid antigen 2 cDNA and immunomapping of NC16A domain by canine bullous pemphigoid autoantibodies.
    Xu L; O'Toole EA; Olivry T; Hernandez C; Peng J; Chen M; Chan LS
    Biochim Biophys Acta; 2000 Jan; 1500(1):97-107. PubMed ID: 10564722
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Linear IgA bullous dermatosis with IgA antibodies exclusively directed against the 180- or 230-kDa epidermal antigens.
    Ghohestani RF; Nicolas JF; Kanitakis J; Claudy A
    J Invest Dermatol; 1997 Jun; 108(6):854-8. PubMed ID: 9182810
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of antigens recognized by autoantibodies in herpes gestationis. Usefulness of immunoblotting using a fusion protein representing an extracellular domain of the 180 kD bullous pemphigoid antigen.
    Murakami H; Amagai M; Higashiyama M; Hashimoto K; Chorzelski TP; Bhogal BS; Jenkins RE; Black MM; Zillikens D; Nishikawa T; Hashimoto T
    J Dermatol Sci; 1996 Nov; 13(2):112-7. PubMed ID: 8953410
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Difference in binding sites of autoantibodies against 230- and 170-kD bullous pemphigoid antigens on salt-split skin.
    Onodera Y; Shimizu H; Hashimoto T; Ishiko A; Ebihara T; Tanaka M; Nishikawa T
    J Invest Dermatol; 1994 May; 102(5):686-90. PubMed ID: 8176249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preferential Reactivity of Dipeptidyl Peptidase-IV Inhibitor-Associated Bullous Pemphigoid Autoantibodies to the Processed Extracellular Domains of BP180.
    Mai Y; Nishie W; Izumi K; Shimizu H
    Front Immunol; 2019; 10():1224. PubMed ID: 31191560
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative sensitivity of indirect immunofluorescence to immunoblot assay for the detection of circulating antibodies to bullous pemphigoid antigens 1 and 2.
    Ghohestani R; Kanitakis J; Nicolas JF; Cozzani E; Claudy A
    Br J Dermatol; 1996 Jul; 135(1):74-9. PubMed ID: 8776363
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunoreactivity of bullous pemphigoid (BP) autoantibodies against the NC16A and C-terminal domains of the 180 kDa BP antigen (BP180): immunoblot analysis and enzyme-linked immunosorbent assay using BP180 recombinant proteins.
    Nakatani C; Muramatsu T; Shirai T
    Br J Dermatol; 1998 Sep; 139(3):365-70. PubMed ID: 9767278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bullous pemphigoid of childhood: autoantibodies target the same epitopes within the NC16A domain of BP180 as autoantibodies in bullous pemphigoid of adulthood.
    Chimanovitch I; Hamm H; Georgi M; Kroiss M; Stolz W; Apitz C; Bröcker EB; Zillikens D
    Arch Dermatol; 2000 Apr; 136(4):527-32. PubMed ID: 10768652
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunoblot analysis of autoantigens in localized pemphigoid and pemphigoid nodularis.
    Kawahara Y; Matsumura K; Hashimoto T; Nishikawa T
    Acta Derm Venereol; 1997 May; 77(3):187-90. PubMed ID: 9188867
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bullous pemphigoid sera react specifically with various domains of BP230, most frequently with C-terminal domain, by immunoblot analyses using bacterial recombinant proteins covering the entire molecule.
    Hamada T; Nagata Y; Tomita M; Salmhofer W; Hashimoto T
    Exp Dermatol; 2001 Aug; 10(4):256-63. PubMed ID: 11493314
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IgG4 and IgE are the major immunoglobulins targeting the NC16A domain of BP180 in Bullous pemphigoid: serum levels of these immunoglobulins reflect disease activity.
    Döpp R; Schmidt E; Chimanovitch I; Leverkus M; Bröcker EB; Zillikens D
    J Am Acad Dermatol; 2000 Apr; 42(4):577-83. PubMed ID: 10727301
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.